Maintenance of telomere length in AML

Slides:



Advertisements
Similar presentations
Telomeres and epigenetics
Advertisements

Alterations in the Cell Cycle and Gene Mutations that Cause Cancer
ATM John Berry. What is ATM? Named “ATM” for “Ataxia-telangiectasia Mutated” gene. The mutation is recessive. Named “ATM” for “Ataxia-telangiectasia Mutated”
TELOMERES Dr. José María Romero Romero. TELOMERES are specialized structures at the end of all eukaryotic chromosomes. contain longthy streches of non-coding.
Anatomy and Physiology 3/15 and 3/16
TELOMERES What are they? Why are they important? Telomere shortening and the end-replication problem Telomerase Telomere hypothesis of aging.
TELOMERES Dr. José María Romero Romero. TELOMERES are specialized structures at the end of all eukaryotic chromosomes. contain longthy streches of non-coding.
Cancer, Aging and Telomeres How molecular genetic research contributes to a better understanding of cancer and aging in humans.
Hallmarks of Cancer Six fundamental changes 1.Self sufficiency in growth factors 2.Insensitivity to growth-inhibitory signals 3.Evasion of apoptosis 4.Limitless.
Ataxia- telangiectasia Mutated (ATM) Brooke Register.
A Review Article by Rune Toftgard, Member of the Nobel Assembly ( about the research that was awarded by 2009 Nobel prize.
Telomeres are repeating sequences that allow cells to distinguish the ends of chromosomes from broken DNA ends. Telomeres prevent DNA damage – they allow.
Can Humans Live Forever? Human beings do not live forever because the human body cannot maintain itself indefinitely. We either grow old or we get diseased.
Cellular Senescence: A Link between Tumor Suppression and Organismal Aging.
Mutations in Replication What did you learn in your reading? Who performs mismatch repair? Why does DNA constantly have to be maintained? What.
Cancer Uncontrolled cell growth. Cellular differentiation is the process by which a less specialized cell becomes a more specialized cell type. Occurs.
Cancer. Regulation of Cell Division Two sets of genes control cell division. –Proto-oncogenes. Code for proteins that promote the cell cycle and prevent.
CANCER Definition Abnormal growth of cells that invade tissues and spread to other sites. Cell Regulation Normal Mitosis Reproduction occurs only when.
The aging phenotype: cellular aspects A&S Jim Lund.
CDK and cyclins The progression of cell cycle is catalyzed by cyclin-dependent kinase (CDK) which, as the name suggests, is activated by a special class.
The Molecular Basis of Heredity Chapter 16. Learning Target 1 I can explain why researchers originally thought protein was the genetic material.
DNA Replication Replication: The process before a cell divides, it duplicates and copies its DNA. DNA  DNA Remember: Each strand can be used to make.
Telomerase, Immortalization and Cancer Eric Bankaitis Cancer Bio 169 March 9, 2006 Fig.[9]
Stem cell concepts renew cancer research by John E. Dick Blood Volume 112(13): December 15, 2008 ©2008 by American Society of Hematology.
Replication 4. The End Replication Problem: Telomeres shorten with each S phase Ori DNA replication is bidirectional Polymerases move 5' to 3' Requires.
TELOMERES &TELOMERASE 18 th Lecture Gihan E-H Gawish, MSc, PhD Ass. Professor Molecular Genetics and Clinical Biochemistry Molecular Genetics and Clinical.
Part II.
Telomeres Aging and Cancer. Replicating the Ends of DNA Molecules Limitations of DNA polymerase create problems for the linear DNA of eukaryotic chromosomes.
AP Biology Discussion Notes Thursday 2/25/2016. Goals for Today Be able to use our biology knowledge to think about (and make) important decisions. Be.
What about the ends (or telomeres) of linear chromosomes? DNA polymerase/ligase cannot fill gap at end of chromosome after RNA primer is removed. this.
Gene mutation and sickle cell (k) explain the effect of the gene mutation resulting in sickle cell anaemia on the structure and oxygen transport efficiency.
Margaret L. Gulley, Thomas C. Shea, Yuri Fedoriw 
ΤΕΛΟΜΕΡΗ.
The Science of Aging Why We Grow Old and Die.
Houston, we have a problem!
Alterations in the Cell Cycle and Gene Mutations that Cause Cancer
DNA Replication Lecture #23 Ms. Day Honors Biology.
Enabling Replicative Immortality
DNA Replication (12.3).
Relationship between Genotype and Phenotype
Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene by A.
by Laurence J. N. Cooper, Kevin M. Shannon, Michael R
Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival by Kai-Da Wu, Lisa.
Margaret L. Gulley, Thomas C. Shea, Yuri Fedoriw 
Ataxia- Telangiectasia and ATM
RNA processing and transport RNA degradation Translation
Control of DNA Replication
M.B.Ch.B, MSC, DCH (UK), MRCPCH
Lesson 3 Thursday, 11/14 AIM: What is a telomere?
The Blue People of Kentucky
Defects in lymphocyte telomere homeostasis contribute to cellular immune phenotype in patients with cartilage-hair hypoplasia  Geraldine Aubert, PhD,
Chromosome structures
Complex Inheritance and Human Heredity
What Integration Sites Tell Us about HIV Persistence
Barbara A. Gilchrest, Mark S. Eller 
Immortal Strands? Give Me a Break
by Geling Li, Emily Waite, and Julie Wolfson
Switching and Signaling at the Telomere
Gene mutation and sickle cell (k) explain the effect of the gene mutation resulting in sickle cell anaemia on the structure and oxygen transport efficiency.
Impact of RTEL1 variants on telomere maintenance.
How to prevent and cure cancer and live forever
Significant differences in translational efficiencies of DNA damage repair pathway genes between patient clusters. Significant differences in translational.
Strategy for mutant telomere synthesis in human cancer cells.
If one assumes that spontaneous mutations can occur with approximately each 20 cell divisions (about 1 million cells), and assuming that mutations provide.
HoxA9 directly regulates cell cycle control genes.
Schematic design of the SSM
Are Mouse Telomeres Going to Pot?
Anne Houtman • Megan Scudellari • Cindy Malone
Mesenchymal Stem Cell-Derived Vesicles Reverse Hematopoietic Radiation Damage by Sicheng Wen, Laura R Goldberg, Mark S Dooner, John L Reagan, and Peter.
Presentation transcript:

Maintenance of telomere length in AML by Peter M. Lansdorp BloodAdv Volume 1(25):2467-2472 November 28, 2017 © 2017 by The American Society of Hematology

Telomere repeats and the DNA damage response. Telomere repeats and the DNA damage response. Telomeres have very specific sequences of repeats along their length, and at least 12 TTAGGG repeats and their associated proteins are required for the telomere to execute its primary function. If there are insufficient repeats, the telomere looks like a double-strand break. Such an “uncapped” telomere will activate a DNA damage response involving the Ataxia-Telangiectasia mutated (ATM) kinase and p53. Peter M. Lansdorp Blood Adv 2017;1:2467-2472 © 2017 by The American Society of Hematology

The telomerase enzyme complex. The telomerase enzyme complex. Telomerase contains a polymerase protein called TERT and an RNA template, TERC, which encodes the G-rich repeats. Chromosomes always end with a single-stranded 3′ DNA overhang believed to invade into telomere duplex DNA if sufficient repeats are available. Peter M. Lansdorp Blood Adv 2017;1:2467-2472 © 2017 by The American Society of Hematology

Telomere length declines with age in human lymphocytes measured using flow FISH. The left panel shows that the average difference in telomere length between females (pink) and males (blue) persist throughout life. Telomere length declines with age in human lymphocytes measured using flow FISH. The left panel shows that the average difference in telomere length between females (pink) and males (blue) persist throughout life. The right panel shows the telomere length in individuals with “telomeropathies,” in this case, heterozygous carriers of a mutation in either the TERC or the TERT gene (red) and their unaffected siblings (purple). Figure adapted from data shown in Aubert et al.18 Peter M. Lansdorp Blood Adv 2017;1:2467-2472 © 2017 by The American Society of Hematology

Normal telomerase levels are needed to maintain telomeres and prevent bone marrow failure. Normal telomerase levels are needed to maintain telomeres and prevent bone marrow failure. Each stem cell division results in loss of telomere repeats explaining why the average telomere length in various cell types including granulocytes and lymphocytes declines with age (Figure 3). (A) Illustrative representation of the hematopoietic stem cell hierarchy. (B-C) In normal individuals, an occasional stem cell drops out of the stem cell pool (B, red circle) when too many short telomeres relative to the limited repair capacity provided by telomerase accumulate. In patients with reduced telomerase levels, for example, as a result of mutations in telomerase genes, stem cells start dropping out during development (C), putting a strain on remaining stem cells, which have to undergo more divisions to make up the pool (hence, shorter telomeres) as illustrated in panel D. The net result of this negative feed-forward loop is (1) very short telomeres in patients with telomerase deficiency and (2) eventual loss of stem cells resulting in bone marrow failure. Peter M. Lansdorp Blood Adv 2017;1:2467-2472 © 2017 by The American Society of Hematology

Telomere length in CML. The difference in telomere length between CML blast cells relative to T lymphocytes in the same patient correlates with disease progression. Telomere length in CML. The difference in telomere length between CML blast cells relative to T lymphocytes in the same patient correlates with disease progression. See also Figure 3. Most likely cells with defective DNA damage responses are selected when telomeres get critically short, allowing for rapid selection of more malignant, chromosomally unstable cells with additional genetic abnormalities, such as mutations in TERT promoter, amplification of the TERT gene, etc. Figure adapted from Brümmendorf et al.31 Peter M. Lansdorp Blood Adv 2017;1:2467-2472 © 2017 by The American Society of Hematology